Conference Coverage

Advances in ankylosing spondylitis hailed as rheumatology’s story of the year

Publish date: March 9, 2020

 

REPORTING FROM RWCS 2020

Pages

Recommended Reading

Flu vaccine succeeds in TNF inhibitor users
MDedge Family Medicine
Hadlima approved as fourth adalimumab biosimilar in U.S.
MDedge Family Medicine
Consider centralized pain in patients with rheumatic disease
MDedge Family Medicine
Ankylosing spondylitis, axial PsA may be two different diseases
MDedge Family Medicine
Patients taking TNF inhibitors can safely receive Zostavax
MDedge Family Medicine
FDA announces approval of fifth adalimumab biosimilar, Abrilada
MDedge Family Medicine
FDA approves infliximab-axxq for numerous indications
MDedge Family Medicine
Repeat LTBI testing best in patients taking biologics with new risk factors
MDedge Family Medicine
New guideline offers recommendations for reproductive health in patients with rheumatic diseases
MDedge Family Medicine
Meta-analysis highlights safety concerns with interleukin inhibition
MDedge Family Medicine